Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Amino Acids Can Predict CV Disease Risk in Women

By LabMedica International staff writers
Posted on 16 Apr 2018
Results of a recent study supported the hypothesis that plasma BCAAs (branched-chain amino acids) were positively associated with cardiovascular disease (CVD) risk and were linked to an intermediate diagnosis of type II diabetes (T2D).

A branched-chain amino acid (BCAA) is an amino acid having aliphatic side-chains with a branch (a central carbon atom bound to three or more carbon atoms). More...
Among the amino acids found in proteins, there are three BCAAs: leucine, isoleucine, and valine. These three BCAAs are among the nine essential amino acids for humans, accounting for 35% of the essential amino acids in muscle proteins and 40% of the preformed amino acids required by mammals.

Circulating branched-chain amino acids (isoleucine, leucine, and valine) are strong predictors of type II diabetes mellitus (T2D), but their association with cardiovascular disease (CVD) is uncertain. To determine if BCAAs have a role in CVD, investigators at Brigham and Women's Hospital (Boston, MA, USA) measured BCAA levels in blood samples using NMR spectrometry. Of the more than 27,000 women studied, 2,207 experienced a cardiovascular event over the 18-year follow up period.

BCAAs were found to be positively associated with CVD at a degree comparable to LDL-C (low-density lipoprotein cholesterol). BCAAs were associated with coronary events (myocardial infarction, revascularization, and borderline significant association with stroke). The BCAA-CVD association was greater among women who developed T2D before CVD versus women without T2D. Adjusting for LDL-C, an established CVD risk factor, did not attenuate these findings; however, adjusting for HbA1c (glycosylated hemoglobin) and insulin resistance eliminated the associations of BCAAs with CVD.

"We examined more than 27,000 women in the Women's Health Study and found that a one-time measurement of branched chain amino acids in the blood stream - a test that now can be easily done - predicted future risk of cardiovascular events to the same extent and independent of LDL cholesterol and other risk factors," said senior author Dr. Samia Mora, a researcher at the center for lipid metabolomics at Brigham and Women's Hospital. "This was particularly so for women who developed type II diabetes prior to their cardiovascular disease."

The work was published in the March 23, 2018, online edition of the journal Circulation: Genomic and Precision Medicine.

Related Links:
Brigham and Women's Hospital


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Collection and Transport System
PurSafe Plus®
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.